Official Publications VYNE Therapeutics Inc.
Equities
VYNE
US92941V3087
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.800 USD | -1.06% | -5.08% | +20.17% |
Nov. 18 | BTIG Initiates VYNE Therapeutics at Buy With $8 Price Target | MT |
Nov. 07 | Earnings Flash (VYNE) VYNE THERAPEUTICS Reports Q3 Revenue $121,000 | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Official Publications